An actuarial analysis shows that offering lung cancer screening as an insurance benefit would save lives at relatively low cost

Health Affairs, 04/13/2012

Authors also believe that payers and patients should demand screening from high–quality, low–cost providers, thus helping set an example of efficient system innovation.

Print Article Summary Cat 2 CME Report